Top Markets
Coin of the day
CohBar, Inc. CohBar, Inc.

CohBar, Inc.

CWBR
Pozycja w akcjach #38304
CohBar Inc. is a clinical-stage biotechnology company dedicated to the... CohBar Inc. is a clinical-stage biotechnology company dedicated to the discovery and advancement of therapies that leverage mitochondrial biology, known as mitochondria-based therapeutics (MBTs). Their primary objective is to combat chronic conditions and diseases associated with aging. These MBTs are being developed to address a broad spectrum of medical challenges, including non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis (IPF), type 2 diabetes, acute respiratory distress syndrome (ARDS), various cancers, and cardiovascular disorders like Alzheimer's disease. Their flagship clinical asset is CB4211, an innovative, optimized analogue of the MOTS-c mitochondrial-derived peptide. This candidate is currently undergoing Phase Ib evaluation as part of a larger Phase Ia/Ib clinical trial, specifically targeting non-alcoholic steatohepatitis (NASH) and obesity. Beyond their clinical work, CohBar's preclinical portfolio features CB5138 analogs aimed at fibrotic conditions, as well as CB5064 analogs being explored for their potential in treating ARDS linked to COVID-19. Established in 2007, CohBar, Inc. maintains its corporate headquarters in Menlo Park, California.
Cena akcji
$0.41
Ostatnia synchronizacja: 2025-01-23
Kapitalizacja rynkowa
$1.08M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel CohBar, Inc. (CWBR)

Kategoria

Historia ceny akcji dla CohBar, Inc. (CWBR)
Najwyższa cena zamknięcia: $0.41 dnia 2025-01-01

Najniższa cena zamknięcia: $40.85 dnia 2015-01-01
Historia cen akcji firmy CohBar, Inc. od 2015 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2025 -20.04%
2024 -31.92%
2023 -55.78%
2022 -86.40%
2021 -68.20%
2020 -20.77%
2019 -51.89%
2018 -32.62%
2017 143.41%
2016 80.68%
2015 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE